Design of Mucosal Vaccines Against Swine Enteric Coronaviruses: From Antigen Delivery to Immune Activation
Transboundary and Emerging Diseases · 2025-01 · 2025 (1)
DOI: 10.1155/tbed/3230453 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Transboundary and Emerging Diseases, online erschienen am 23.11.2025. Verfasst von Qihao Pan und 13 weiteren Autor:innen. Beteiligte Einrichtung: College of Veterinary Medicine, Henan Agricultural University, Zhengzhou 450046, P. R., China. Hauptthemen laut MEDLINE: Viral Vaccines, Swine Diseases, Immunity, Mucosal, Coronavirus Infections. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 131 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Henan Province.
Abstract (Originalsprache)
Swine enteric coronaviruses (SeCoVs) cause acute enteritis and high mortality in neonatal piglets, posing a significant threat to the swine industry. Injectable vaccines often fail to induce effective mucosal immunity, and their efficacy is further compromised by maternally derived antibodies. Oral and intranasal mucosal vaccines offer promising alternatives, enabling localized and durable protection. This review summarizes recent advances in mucosal vaccines against SeCoVs, focusing on antigen delivery platforms and mucosal immune activation. Novel antigen delivery platforms, including nanoparticles (NPs), hydrogels, engineered probiotics, recombinant viral vectors, and eukaryotic expression systems, have improved antigen stability and facilitated transport across the epithelium to mucosal inductive sites. Moreover, targeting strategies that focus on microfold cells (M cells) and dendritic cells (DCs) enhance antigen uptake and presentation. These delivery systems promote mucosal immune activation by inducing secretory IgA (sIgA), maintaining Th1/Th2 balance, and promoting the generation of T and B cells. In addition, the incorporation of adjuvants further strengthens these responses, resulting in more robust and durable protection. By synergistically integrating advanced mucosal vaccine delivery systems with rational adjuvant strategies, this review provides theoretical and practical perspectives for the development of safe, effective, and broadly protective mucosal vaccines targeting SeCoVs infections.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- College of Veterinary Medicine, Henan Agricultural University, Zhengzhou 450046, P. R., China.
- Ministry of Education Key Laboratory for Animal Pathogens and Biosafety, Zhengzhou 450046, P. R., China.
- Henan Province Key Laboratory for Animal Food Pathogens Surveillance, Zhengzhou 450046, P. R., China.
- Longhu Laboratory of Henan Province, Zhengzhou 450046, P. R., China.
ORCID-Profile: Qihao Pan, Yinhe Sun, Haojie Bai, Wenqian Wang, Borui Liu, Muzi Li, Ao Gao, DongFang Zheng, Weili Jiang, Hui Hu, Honglei Zhang, Yuqiang Xiang, Zhanyong Wei, Lanlan Zheng
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation of Henan Province
Zitieren
APA
Pan, Q., Sun, Y., Bai, H., Wang, W., Liu, B., Li, M., Gao, A., Zheng, D., Jiang, W., Hu, H., Zhang, H., Xiang, Y., Wei, Z., & Zheng, L. (2025). Design of Mucosal Vaccines Against Swine Enteric Coronaviruses: From Antigen Delivery to Immune Activation. Transboundary and Emerging Diseases, 2025(1). https://doi.org/10.1155/tbed/3230453
Vancouver
Pan Q, Sun Y, Bai H, Wang W, Liu B, Li M, et al. Design of Mucosal Vaccines Against Swine Enteric Coronaviruses: From Antigen Delivery to Immune Activation. Transboundary and Emerging Diseases. 2025;2025(1). doi:10.1155/tbed/3230453
BibTeX
@article{Pan2025,
author = {Pan, Qihao and Sun, Yinhe and Bai, Haojie and Wang, Wenqian and Liu, Borui and Li, Muzi and Gao, Ao and Zheng, DongFang and Jiang, Weili and Hu, Hui and Zhang, Honglei and Xiang, Yuqiang and Wei, Zhanyong and Zheng, Lanlan},
title = {Design of Mucosal Vaccines Against Swine Enteric Coronaviruses: From Antigen Delivery to Immune Activation},
journal = {Transboundary and Emerging Diseases},
year = {2025},
volume = {2025},
number = {1},
doi = {10.1155/tbed/3230453}
}
EUVIMED